Commercial

INTERPHEX

August 16, 2017

Led by Over 450 Deals, the Biopharmaceutical Contract Manufacturing Market Likely to Witness 8.7% Growth, Predicts Roots Analysis

August 16, 2017

LONDON–(BUSINESS WIRE)–Roots Analysis has announced release of the 2nd edition of its “Biopharmaceutical Contract Manufacturing Market, 2017 – 2027” report.   “Biopharmaceutical Contract Manufacturing Market, 2017 – 2027” Tweet this Snehasish Das, the principal analyst, stated, “We estimate the current global contract biopharmaceutical manufacturing capacity to be over 3.4 million liters. The development and manufacturing […]

Amicus Therapeutics Announces Approval for Galafold™ (Migalastat) for Treatment of Fabry Disease in Australia

August 16, 2017

CRANBURY, N.J., Aug. 15, 2017 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq:FOLD) announced that the Australian Therapeutic Goods Administration (TGA) has approved the oral precision medicine Galafold for long-term treatment of adults and adolescents aged 16 years and older with a confirmed diagnosis of Fabry disease (alpha-galactosidase A deficiency) and who have an amenable mutation. Amicus […]

Gene Therapy R&D and Revenue Forecasts 2017-2027

August 16, 2017

LONDON, August 15, 2017 /PRNewswire/ —   Cancer, Cardiovascular, Rare Diseases, Ophthalmologic, Other Diseases   The gene therapy market is projected to grow at a CAGR of 40.8% in the first half of the forecast period. In 2016, the cancer treatment submarket accounted for 75.0% of the gene therapy drug market. Visiongain estimated that gene […]

Novartis’ Cosentyx Beginning to Plateau in Psoriatic Arthritis, as US Rheumatologists Prepare for an Influx of Non-TNF Agents, Such as BMS’ Orencia, Pfizer’s Xeljanz, and Lilly’s IL-17, Taltz Despite an increasing user base, Cosentyx share has remained unchanged over the past six months, according to recently released data from Spherix Global Insights

August 16, 2017

EXTON, Pa., Aug. 15, 2017 /PRNewswire/ — In the most recent quarterly update of RealTime Dynamix™ Psoriatic Arthritis, a growing population of US rheumatologists (n=101) are reporting use of Cosentyx to treat their patients with psoriatic arthritis (PsA). Nonetheless, this increasing user base has not translated into overall increases in biologic share. Furthermore, in Q2 […]

Shuttle Pharmaceuticals and POLA Pharma Inc. Agree to License U.S. Rights to Doranidazole

August 16, 2017

ROCKVILLE, Md., Aug. 15, 2017 /PRNewswire/ — Shuttle Pharmaceuticals, Inc. (USA) and POLA Pharma Inc. (Japan), today announced agreement to license the U.S. rights for doranidazole, a hypoxic cell radiation sensitizer, for clinical development in treating cancers in combination with stereotactic body radiation therapy (SBRT). SBRT is used to deliver large doses of radiation in […]

Clinical Trials Market Size Worth $65.2 Billion by 2025 | CAGR: 5.7%: Grand View Research, Inc.

August 16, 2017

SAN FRANCISCO, August 16, 2017 /PRNewswire/ —   The global clinical trials market is expected to reach USD 65.2 billion by 2025, according to a new report by Grand View Research, Inc. Key drivers impacting the market growth are globalization of clinical trials, development of new treatments such as personalized medicine, augmenting evolution in technology, […]

Monsanto and Toolgen Announce Global Licensing Agreement on Crispr Platform, Underscore the Benefits of Innovation for Farmers

August 16, 2017

LOUIS and SEOUL, SOUTH KOREA (August 16, 2017) – Monsanto Company (NYSE: MON) and ToolGen, Inc. (KONEX, 199800), a biotechnology company specializing in genome editing, announced today that the companies have reached a global licensing agreement for the use of ToolGen’s CRISPR technology platform to develop agricultural products. ToolGen is an early pioneer in gene […]

Survey of Payers and Gastroenterologists Finds Excitement Over the Prospect of JAK Inhibitors to Treat Inflammatory Bowel Disease

August 15, 2017

BURLINGTON, Mass., Aug. 8, 2017 /PRNewswire/ — Decision Resources Group finds that surveyed health insurance medical and pharmacy directors as well as gastroenterologists look favorably on Janus kinase (JAK) inhibitors for use in Inflammatory Bowel Disease (IBD). A majority of surveyed payers regarded Pfizer’s Xeljanz (tofacitinib) and Gilead/Galapagos’ filgotinib as the emerging therapies that will […]

BioreclamationIVT Acquires Biospecimen and Research Services Provider Asterand Bioscience

August 15, 2017

Acquisition broadens BioreclamationIVT’s disease-state biospecimen capabilities, particularly in oncology, and expands its scientific service offerings for diagnostic and drug development researchers BioreclamationIVT, a leading provider of biospecimens and related services, today announced that it has acquired Asterand Bioscience™, a global provider of high quality, well-characterized human tissue and research solutions with a focus on the […]

Insulin Delivery Devices Market to Reach US$20.9 Billion by 2025; Growing Prevalence of Diabetes Driving Demand

August 15, 2017

ALBANY, New York, August 14, 2017 /PRNewswire/ —   As per the findings of a recent study by Transparency Market Research (TMR), the global insulin delivery devices market is largely fragmented, owing to the presence of a number of global players as well as quite a few local players. Some of the key companies identified […]

Shire announces submission of lifitegrast Marketing Authorization Application for treatment of dry eye disease in Europe

August 15, 2017

Zug, Switzerland – 15 August – Shire plc (LSE: SHP, NASDAQ: SHPG) announces that the Marketing Authorization Application (MAA) for lifitegrast, submitted on 07 August 2017, has been validated by the UK as the Reference Member State involved in the Decentralized Procedure (DCP). If approved, lifitegrast would be the first and only treatment in a […]

Worldwide Clinical Trials’ Experts to Advance Discussion on Innovative Strategies for Translational Research Services

August 15, 2017

MORRISVILLE, NC, AUG 14, 2017 – To advance dialogue on uncommon approaches to clinical research and development challenges, Worldwide Clinical Trials (www.worldwide.com) will host the next in its series of ‘Eavesdropping on the Experts’ webinars, titled “When Phase Matters: Innovative Strategies for Translational Research Services.” Worldwide clinical research experts in early development, bioanalytical sciences and […]

Grant Thornton names George Serafin national managing principal of Health Care and Life Sciences practice

August 15, 2017

ISELIN, N.J., August 10, 2017— Grant Thornton LLP has named George Serafin national managing principal of the firm’s Health Care and Life Sciences industry practice. In addition to his new national leadership role overseeing the delivery of audit, tax and consulting services within this industry group, he continues to lead Grant Thornton’s Advisory Services’ Health […]

Certara Introduces Externalization Technology to its D360 Scientific Informatics Platform

August 15, 2017

D360 Partner™ Provides Secure Data Access and Facilitates Collaboration on Drug Discovery Projects between Pharmaceutical Research Teams at Multiple Organizations Certara®, the global leader in model-informed drug development and regulatory science, today announced that it has added externalization technology to its D360 scientific informatics platform. The resulting new product, D360 Partner, facilitates collaboration between sponsors […]

Corporate Reputation of Pharma Companies, 2016-2017 From the Perspective of 251 Cancer Patient Groups – Research and Markets

August 14, 2017

DUBLIN–(BUSINESS WIRE)–The “The Corporate Reputation of Pharma Companies, 2016: from the Perspective of 251 Cancer Patient Groups – 3rd Edition” report has been added to Research and Markets’ offering.   “The Corporate Reputation of Pharma Companies, 2016: from the Perspective of 251 Cancer Patient Groups – 3rd Edition” Tweet this These results are derived from […]

Vaccines Market Worth 49.27 Billion USD by 2022

August 14, 2017

PUNE, India, August 14, 2017 /PRNewswire/ —   According to a new market research report “Vaccine Market by Technology (Live, Conjugate, Toxoid, Recombinant), Disease (Influenza, DTaP, HPV, Hepatitis, Rotavirus, TT, Polio, MMR, Varicella, Dengue, TB, Rabies), Route (IM, SC, ID, Oral), End User (Pediatric, Adult) & Type – Forecast to 2022”, published by MarketsandMarkets™, the […]

FEEDBACK